Citation & Authors
Nutrients. 2025;17(24):3908.
ABSTRACT · CHINESE TRANSLATION
Translated abstract
Translated from the licensed abstract via the Chinese version. This is not an official journal translation.
background
Type 2 diabetes is a growing global health challenge requiring effective dietary management strategies. The Mediterranean diet has potential cardiovascular and metabolic benefits, but the last comprehensive meta-analysis of randomized controlled trials examining its effects on glycemic control and body mass index (BMI) was published in 2015. Multiple trials have since been completed, including culturally adapted interventions and those with extended follow-up, but their findings have not yet been synthesized.
method
This systematic review and meta-analysis followed PRISMA 2020 (PROSPERO: CRD420251147035) and searched PubMed, Web of Science, and Embase from inception through August 17, 2025. Unlike previous analyses combining observational cohorts or multiple dietary patterns, it was restricted to randomized controlled trials in adults with established type 2 diabetes, published after 2015, comparing Mediterranean with non-Mediterranean control diets. Primary outcomes were HbA1c, fasting plasma glucose (FPG), and BMI; secondary outcomes were LDL-C, systolic blood pressure (SBP), and diastolic blood pressure (DBP). Pooled effects were estimated using random-effects models.
result
11 trials (10 publications) involving diverse populations met the eligibility criteria. Compared with control diets, the Mediterranean diet reduced HbA1c (mean difference [MD] −0.307%; 95% CI −0.451 to −0.163), FPG (−0.845 mmol/L; −1.307 to −0.384), and BMI (−0.828 kg/m²; −1.4 to −0.256). In secondary analyses, the mean difference was −8.060 mg/dL (−14.213 to −1.907) for LDL-C, −5.130 mmHg (−10.877 to 0.617) for SBP, and −2.008 mmHg (−3.027 to −0.989) for DBP. Sensitivity analyses supported the stability of the findings, and no evident publication bias was detected. Blood pressure responses varied geographically, with greater benefits in non-Mediterranean populations.
Conclusion
In adults with type 2 diabetes, the Mediterranean diet was associated with modest improvements in glycemic control, body composition, and cardiometabolic risk factors. Its cultural adaptability may facilitate clinical implementation, but larger multicenter trials with standardized protocols and longer follow-up are needed.
Original work: Author of the above paper. Source:Public Summary ↗. This translation is based on the Chinese rendering of the original English abstract.
Original work license:CC BY ↗;Translations are subject to the same licensing conditions.
